{
    "clinical_study": {
        "@rank": "109094", 
        "arm_group": [
            {
                "arm_group_label": "CBGT+ABMT(active)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "CBGT+ABMT(placebo)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "PCI+ABMT(active)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "PCI+ABMT(placebo)", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this project is to test the combination of active or placebo Attentional\n      Bias Modification Treatment (ABMT) to either Cognitive Behavioral Group Therapy (CBGT) or\n      Psychoeducational Control Intervention (PCI) for anxiety disorders in children."
        }, 
        "brief_title": "Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Generalized Anxiety Disorder", 
            "Separation Anxiety Disorder", 
            "Social Anxiety Disorder"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Anxiety, Separation", 
                "Mental Disorders", 
                "Phobic Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Primary diagnosis of Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder\n             (SeAD) or Social Anxiety Disorder (SoAD) according to KSADS-PL psychiatric interview\n\n        Exclusion Criteria:\n\n          -  Other psychiatric disorder that causes more impairment and suffering than GAD, SeAD\n             or SoAD in the clinical evaluation\n\n          -  Current or previous treatment (behavioral or pharmacological) for a psychaitric\n             disorder in childhood\n\n          -  IQ < 70 (Raven)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "11 Years", 
            "minimum_age": "7 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 26, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687764", 
            "org_study_id": "HCPA11-0249"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "CBGT+ABMT(active)", 
                    "PCI+ABMT(active)"
                ], 
                "description": "The ABMT consists of 160 trials (120 angry-neutral and 40 neutral-neutral presentations). In the ABM condition, the target  appears at the neutral-face location in all angry-neutral trials. Probe type (< or >) is not factorially counterbalanced but appears with equal probability for each of the following: angry-face location, probe location, or actor.", 
                "intervention_name": "Attentional Bias Modification Treatment (ABMT) - Active", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "CBGT+ABMT(placebo)", 
                    "PCI+ABMT(placebo)"
                ], 
                "description": "The Placebo protocol consists of 160 trials (120 angry-neutral and 40 neutral-neutral presentations). In the placebo condition, angry-face location, probe location, and actor are fully counterbalanced in presentation.", 
                "intervention_name": "Attentional Bias Modification Treatment - Placebo", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "CBGT+ABMT(active)", 
                    "CBGT+ABMT(placebo)"
                ], 
                "description": "\"FRIENDS for Life\" Australian protocol for the treatment of anxiety disorders in children", 
                "intervention_name": "Cognitive Behavioral Group Therapy", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "PCI+ABMT(active)", 
                    "PCI+ABMT(placebo)"
                ], 
                "description": "Psychoeducational control intervention provides only brief psychoeducational information about anxiety associated with general educational activities", 
                "intervention_name": "Psychoeducational Control Intervention", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Generalized Anxiety Disorder (GAD)", 
            "Separation Anxiety Disorder (SeAD)", 
            "Social Anxiety Disorder (SoAD)"
        ], 
        "lastchanged_date": "September 14, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bethesda", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20892"
                    }, 
                    "name": "National Institute of Mental Health (NIMH)"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brisbane St Lucia", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4072"
                    }, 
                    "name": "University of Queensland"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "gsalumjr@gmail.com", 
                    "last_name": "Giovanni A Salum Junior, MD", 
                    "phone": "+55 51 33598983"
                }, 
                "contact_backup": {
                    "email": "rafaelabehs@hotmail.com", 
                    "last_name": "Rafaela Behs, MSc", 
                    "phone": "+55 51 33598983"
                }, 
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "Rio Grande do Sul", 
                        "zip": "90035-003"
                    }, 
                    "name": "Federal University of Rio Grande do Sul / Hospital de Cl\u00ednicas de Porto Alegre (HCPA)"
                }, 
                "investigator": [
                    {
                        "last_name": "Gisele G Manfro, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Silvia H Koller, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Giovanni A Salum Junior, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Circe S Petersen, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Rudineia Toazza", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Rafaela B Jarros, MSc", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Diogo Souza", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tel-Aviv", 
                        "country": "Israel", 
                        "zip": "69987"
                    }, 
                    "name": "Tel-Aviv University"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "Brazil", 
                "Israel"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children: a Randomized Clinical Trial", 
        "overall_contact": {
            "email": "gmanfro@portoweb.com.br", 
            "last_name": "Gisele G Manfro, MD, PhD", 
            "phone": "+55 51 3359 8983"
        }, 
        "overall_contact_backup": {
            "email": "gsalumjr@gmail.com.br", 
            "last_name": "Giovanni A Salum Junior, MD", 
            "phone": "+55 51 3359 8983"
        }, 
        "overall_official": [
            {
                "affiliation": "Federal University of Rio Grande do Sul / Hospital de Cl\u00ednicas de Porto Alegre", 
                "last_name": "Gisele G Manfro, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Federal University of Rio Grande do Sul / University of Psychology", 
                "last_name": "Silvia H Koller, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Brazil: Ethics Committee", 
                "Brazil: National Committee of Ethics in Research"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Score change on Pediatric Anxiety Rating Scale (PARS) from baseline to week 10 and to 6-month follow-up", 
                "measure": "Pediatric Anxiety Rating Scale (PARS) / continuous", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week 10) and 6-month follow-up"
            }, 
            {
                "description": "Percentage of subjects with less than 2 points in the CGI-I scale in week 10 and in 6-month follow-up", 
                "measure": "Clinical Global Impression - Improvement Scale (CGI-I) / dichotomous", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week-10) and 6-month follow-up"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687764"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Score change in SCARED child and parent versions from baseline to week 10 and 6-months follow-up", 
                "measure": "Screen for Children and Anxiety Related Emotional Disorders (SCARED)", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week-10) and 6-months follow-up"
            }, 
            {
                "description": "Score change in CDI from baseline to week-10 and to 6-month follow-up", 
                "measure": "Childhood Depression Inventory (CDI)", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week-10) and 6-month follow-up"
            }, 
            {
                "description": "Score change in SNAP-IV from baseline to week-10 and 6-month follow-up", 
                "measure": "Swanson, Nolan, and Pelham scale - Version IV (SNAP-IV)", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week-10) and 6-month follow-up"
            }, 
            {
                "description": "Score change in SCAS from baseline to week-10 and to 6-month follow-up", 
                "measure": "Spence Children's Anxiety Scale (SCAS)", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week-10) and 6-month follow-up"
            }, 
            {
                "description": "Change in neuropsychological measures from baseline to week-10 and 6-month follow-up", 
                "measure": "Neuropsychological measures", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week-10) and 6-month follow-up"
            }, 
            {
                "description": "Change in biological measures from baseline to week-10 and to 6-month follow-up", 
                "measure": "Biological measures", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week-10) and 6-month follow-up"
            }
        ], 
        "source": "Hospital de Clinicas de Porto Alegre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital de Clinicas de Porto Alegre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}